Network meta-analysis of 15 RCTs (48 904 PCI patients): vs clopidogrel, prasugrel lowered MACE (OR 0.80) and ticagrelor did not, though ticagrelor raised major bleeding (OR 1.24). Prasugrel also had lower MACE than ticagrelor (OR 0.83).
Meta-analysisn = 48,904
Maqsood et al. Efficacy and Safety of Prasugrel, Ticagrelor, or Clopidogrel After Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis